Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK

Juan J. Sironi, Shu Hui Yen, Javed A. Gondal, Qiongli Wu, Inge Grundke-Iqbal, Khalid Iqbal

Research output: Contribution to journalArticle

63 Scopus citations

Abstract

Several kinases have been shown to phosphorylate tau protein at Ser-262, an important site involved in the regulation of the binding of tau to microtubules. In this study we compared the phosphorylation of tau at Ser-262 by CaMKII, PhK and PKA in vitro as determined by radioimmunoblots developed by the monoclonal antibody 12E8 which recognizes P-Ser-262 and P-Ser-356; and Ab-262, a polyclonal antibody which is specific to unphosphorylated Ser-262 in tau. We found that the phosphorylation at Ser-262 was several times more effective by CaMKII than PKA or PhK. Employing rat brain extract as a source of all brain kinases and KN-62, a specific inhibitor of CaMKII, we found that CaMKII accounts for ~45% of phosphorylation at Ser-262. Furthermore, in rat brain slices kept metabolically active in oxygenated artificial CSF, phosphorylation of tau at Ser-262 was (i) increased up to 120% in the presence of bradykinin, a CaMKII activator, and (ii) inhibited by ~35% in the presence of KN-62. Thus, CaMKII is a major tau Ser-262 kinase in mammalian brain. Copyright (C) 1998 Federation of European Biochemical Societies.

Original languageEnglish (US)
Pages (from-to)471-475
Number of pages5
JournalFEBS Letters
Volume436
Issue number3
DOIs
StatePublished - Oct 9 1998

    Fingerprint

Keywords

  • Alzheimer's disease
  • Calcium calmodulin kinase II
  • Phosphorylase kinase
  • Protein kinase A
  • Ser-262
  • Tau phosphorylation

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this